CBC (cannabichromene) is an important cannabinoid that has anti-inflammatory and antimicrobial effects. Broad spectrum CBC soft gels do not produce a psychoactive effect. However, CBC is an effective anti-inflammatory, antioxidant, and analgesic agent when administered separately from the other cannabinoids.
The benefits of combining other cannabinoids with low doses of THC have also been studied for relieving pain. Some studies have shown that other cannabinoids modulate how the receptors respond to THC while limiting its psychoactive effects.
CBC act as an antioxidant, anti-inflammatory, and neuroprotective agent
CBC is an antioxidant, anti-inflammatory, and neuroprotective agent. It has also been shown to be an effective analgesic (pain reliever) when administered in low doses without the psychoactive side effects of high doses of THC. CBC can enhance the pain relief provided by a higher dose of THC when they are combined.
Broad-spectrum CBS soft gels offer a mild relief from various conditions
There is no evidence that the cannabinoids found in full-spectrum CBD soft gels interact with receptors other than CB 1 or CB 2 receptors while not producing mental impairment. This means that full-spectrum CBD soft gels medications do not produce a high or disorientation but rather provide mild symptomatic relief from conditions such as muscle spasms, nausea, inflammation, and headaches without the risk of severe side effects associated with high doses of THC.
While full spectrum CBD soft gels have mild psychoactive effects, low-dose full spectrum CBC soft gels effectively treat pain without the severe mental impairment induced by higher doses of THC. This makes them suitable for use during the day, especially in patients with multiple sclerosis or other debilitating conditions involving chronic pain.
Many patients who use full-spectrum CBD soft gels report feeling relaxed, happy, and hungry following administration. They also say that they experience less pain than when they were not taking the medication.